Dr. Babak Kateb, Founding Chairman of the Board of the Society for Brain Mapping & Therapeutics and Director of National Center for NanoBioElectronics
The Society for Brain Mapping and Therapeutics (SBMT) is a multidisciplinary and multispecialty non-profit biomedical association organized for the purpose of encouraging basic and clinical scientists who are interested in areas of Brain Mapping, engineering, stem cell, nanotechnology, imaging and medical device to improve the diagnosis, treatment and rehabilitation of patients afflicted with neurological disorders.
Founded in 2003 with the aim of filling the educational gap between biological and physical science disciplines, the organization came about after a successful collaboration between NASA/JPL, Keck School of Medicine of USC, and Caltech. Since then, the Society has held 13 annual world congresses in the US, France, Canada and Australia, established its own Brain Atlas, published the inaugural textbook of nanoneurosurgery and been a driving force behind President Obama’s BRAIN initiative. In 2014, the Society launched the G20 World Brain Mapping and Therapeutics conference in Brisbane in order to develop global cooperation and partnership for brain discovery and repair.
The Society is a leader in the field of Brain Mapping and Therapeutics and could be considered as the world’s fastest growing translational neuroscience think-tank, with near 4,000 members – consisting of scientists, surgeons, physicians and engineers – focussing their attention on narrowing the gap between disciplines. The organization helps to bridge these gaps through annual Conventions and satellite symposia, the SBMT University, journals, prestigious awards, Brain Mapping Days at the US Congress, partnership with National Center for NanoBioElectronics (NCNBE) for translating, integrating and commercializing of advance technologies into clinical trials , student Chapters and its global partnerships with G20 and African Brain Mapping initiatives.
It’s due to this shared cross-disciplinary nature that PLOS ONE and SBMT have, since 2010, partnered on the Neuromapping and Therapeutics Collection.
The aim of the Collection is to provide a forum for interdisciplinary research aimed at translation of knowledge across a number of fields such as neurosurgery, neurology, psychiatry, radiology, neuroscience, neuroengineering, nanoneuroscience/nanoneurosurgery and healthcare policy issues that affect the treatment delivery and usage of certain devices, drugs and imaging technologies.
PLOS ONE’s wide scope and broad publication criteria make it a perfect venue to publish and collate relevant articles in these areas of research into one cross-disciplinary collection. Our hope is that by encouraging and facilitating further research, replication, and sharing of both positive and negative results, this Collection will become a catalyst for continued innovation and discovery in brain mapping and therapeutics.
Join us at the Upcoming 12th Annual SBMT Congress
PLOS will be attending the 12th Annual Congress of SBMT in Los Angeles on March 6-8 and look forward to discussing the Neuromapping and Therapeutics Collection and the PLOS Neuro Community site. In the coming weeks, society members will be blogging about their research and why they value being a member of SBMT.
For more information about the collection – or PLOS Collections in general – contact firstname.lastname@example.org
Dr. Babak Kateb (@BabakKateb) is the Founding Chairman of the Board of The Society for Brain Mapping & Therapeutics, Research Scientist, Department of Neurosurgery, Cedars Sinai Medical Center and Director of National Center for NanoBioElectronics
Nathaniel Gore (@thengore) is the Editorial Project Manager of PLOS Collections